REPORT ID 4812

EMEA (Europe, Middle East and Africa) Hemostat Powders Market Report 2017

Publish Date
19-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the EMEA Hemostat Powders market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Hemostat Powders for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hemostat Powders market competition by top manufacturers/players, with Hemostat Powders sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Ethicon
    C. R. Bard
    Gelita Medical
    Equimedical
    Biocer
    Celox
    Hemostasis
    MBP
    Medira
    Hemotec Medical
    Starch Medical
    Success Pharmaceutical
    Changsha Hairun

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Microfibrillar Collagen
    Chitosan
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Surgical Wound Care
    General Wound Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Hemostat Powders Market Report 2017
1 Hemostat Powders Overview
    1.1 Product Overview and Scope of Hemostat Powders
    1.2 Classification of Hemostat Powders
        1.2.1 EMEA Hemostat Powders Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Hemostat Powders Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Microfibrillar Collagen
        1.2.4 Chitosan
        1.2.5 Other
    1.3 EMEA Hemostat Powders Market by Application/End Users
        1.3.1 EMEA Hemostat Powders Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Surgical Wound Care
        1.3.3 General Wound Care
    1.4 EMEA Hemostat Powders Market by Region
        1.4.1 EMEA Hemostat Powders Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Hemostat Powders (2012-2022)
        1.5.1 EMEA Hemostat Powders Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Hemostat Powders Revenue and Growth Rate (2012-2022)

2 EMEA Hemostat Powders Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Hemostat Powders Market Competition by Players/Manufacturers
        2.1.1 EMEA Hemostat Powders Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Hemostat Powders Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Hemostat Powders Sale Price by Players (2012-2017)
    2.2 EMEA Hemostat Powders (Volume and Value) by Type/Product Category
        2.2.1 EMEA Hemostat Powders Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Hemostat Powders Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Hemostat Powders Sale Price by Type (2012-2017)
    2.3 EMEA Hemostat Powders (Volume) by Application
    2.4 EMEA Hemostat Powders (Volume and Value) by Region
        2.4.1 EMEA Hemostat Powders Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Hemostat Powders Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Hemostat Powders Sales Price by Region (2012-2017)

3 Europe Hemostat Powders (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Hemostat Powders Sales and Value (2012-2017)
        3.1.1 Europe Hemostat Powders Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Hemostat Powders Revenue and Growth Rate (2012-2017)
    3.2 Europe Hemostat Powders Sales and Market Share by Type
    3.3 Europe Hemostat Powders Sales and Market Share by Application
    3.4 Europe Hemostat Powders Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Hemostat Powders Sales Volume by Countries (2012-2017)
        3.4.2 Europe Hemostat Powders Revenue by Countries (2012-2017)
        3.4.3 Germany Hemostat Powders Sales and Growth Rate (2012-2017)
        3.4.4 France Hemostat Powders Sales and Growth Rate (2012-2017)
        3.4.5 UK Hemostat Powders Sales and Growth Rate (2012-2017)
        3.4.6 Russia Hemostat Powders Sales and Growth Rate (2012-2017)
        3.4.7 Italy Hemostat Powders Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Hemostat Powders Sales and Growth Rate (2012-2017)

4 Middle East Hemostat Powders (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Hemostat Powders Sales and Value (2012-2017)
        4.1.1 Middle East Hemostat Powders Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Hemostat Powders Revenue and Growth Rate (2012-2017)
    4.2 Middle East Hemostat Powders Sales and Market Share by Type
    4.3 Middle East Hemostat Powders Sales and Market Share by Application
    4.4 Middle East Hemostat Powders Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Hemostat Powders Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Hemostat Powders Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Hemostat Powders Sales and Growth Rate (2012-2017)
        4.4.4 Israel Hemostat Powders Sales and Growth Rate (2012-2017)
        4.4.5 UAE Hemostat Powders Sales and Growth Rate (2012-2017)
        4.4.6 Iran Hemostat Powders Sales and Growth Rate (2012-2017)

5 Africa Hemostat Powders (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Hemostat Powders Sales and Value (2012-2017)
        5.1.1 Africa Hemostat Powders Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Hemostat Powders Revenue and Growth Rate (2012-2017)
    5.2 Africa Hemostat Powders Sales and Market Share by Type
    5.3 Africa Hemostat Powders Sales and Market Share by Application
    5.4 Africa Hemostat Powders Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Hemostat Powders Sales Volume by Countries (2012-2017)
        5.4.2 Africa Hemostat Powders Revenue by Countries (2012-2017)
        5.4.3 South Africa Hemostat Powders Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Hemostat Powders Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Hemostat Powders Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Hemostat Powders Sales and Growth Rate (2012-2017)

6 EMEA Hemostat Powders Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hemostat Powders Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Ethicon
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Hemostat Powders Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Ethicon Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 C. R. Bard
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Hemostat Powders Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 C. R. Bard Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Gelita Medical
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Hemostat Powders Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gelita Medical Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Equimedical
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Hemostat Powders Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Equimedical Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Biocer
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Hemostat Powders Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Biocer Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Celox
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Hemostat Powders Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Celox Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Hemostasis
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Hemostat Powders Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hemostasis Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 MBP
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Hemostat Powders Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 MBP Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Medira
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Hemostat Powders Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Medira Hemostat Powders Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Hemotec Medical
    6.12 Starch Medical
    6.13 Success Pharmaceutical
    6.14 Changsha Hairun

7 Hemostat Powders Manufacturing Cost Analysis
    7.1 Hemostat Powders Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hemostat Powders

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hemostat Powders Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hemostat Powders Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Hemostat Powders Market Forecast (2017-2022)
    11.1 EMEA Hemostat Powders Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Hemostat Powders Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Hemostat Powders Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Hemostat Powders Price and Trend Forecast (2017-2022)
    11.2 EMEA Hemostat Powders Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Hemostat Powders Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Hemostat Powders Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Hemostat Powders Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Hemostat Powders Sales Forecast by Type (2017-2022)
    11.7 EMEA Hemostat Powders Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer